Ajanta Pharma Limited (AJANTPHARM)
Healthcare | Drug Manufacturers - Specialty & Generic
₹2554.0
1.72% (₹43.2)
Market Overview
| Market Cap | 319579455488 |
| Volume | 109676 |
| 52W High | ₹3485.0 |
| 52W Low | ₹2111.05 |
Key Ratios
| P/E Ratio | 34.715237 |
| EPS | 73.57 |
| Beta | 0.243 |
| Dividend Yield | 2.15% |
Financial Performance
Revenue Growth
0.11%
Profit Margin
0.19801001%
ROE
0.25019%
ROA
0.14557%
Stock Analysis Score: 70/100
Growth Score: 70/100
Key Strengths:
- Excellent profit margins above 15%
- Strong ROE above 15%
- High PE ratio between 25-35
- Low volatility with beta below 1
- Strong operating margins above 15%
Recommendation
Buy - The stock shows good fundamentals with some room for improvement
Detailed Analysis
Growth: 0.1% revenue growth indicates weak business expansion.
Profitability: 19.8% profit margin shows excellent operational efficiency.
Returns: ROE of 25.0% demonstrates strong return on shareholder investment.
Valuation: PE ratio of 34.7x is expensive compared to market averages.
Trading Decision Guide
- Score 80-100: Consider for long-term investment with high conviction
- Score 60-79: Suitable for medium-term investment with regular monitoring
- Score 40-59: Short-term trading opportunities, maintain strict stop-losses
- Score Below 40: High-risk trading only, thorough research essential
Risk Factors
- Market Cap: ₹31957.9Cr
- Beta: 0.24 (Market Volatility)
- 52-Week Range: ₹2111.1 - ₹3485.0
Last Updated: 2025-06-03 05:34:54